Delayed Sleep Phase Syndrome
|
0.310 |
Biomarker
|
disease |
CTD_human |
The data suggest that AA-NAT could be a susceptibility gene for DSPS.
|
12736803 |
2003 |
Delayed Sleep Phase Syndrome
|
0.310 |
Biomarker
|
disease |
BEFREE |
The data suggest that AA-NAT could be a susceptibility gene for DSPS.
|
12736803 |
2003 |
Depression, Bipolar
|
0.300 |
Biomarker
|
disease |
PSYGENET |
We assessed the contribution of AANAT gene variability to susceptibility to MD considering common and rare genetic variations through a sequential sequencing and single nucleotide polymorphism (SNP)-based genotyping approach in a sample of 445 unrelated patients with MD (257 unipolar MD, 188 bipolar depression) and 440 community-based screened control subjects.
|
20459461 |
2010 |
Nonorganic Sleep Wake Cycle Disorders
|
0.300 |
Biomarker
|
disease |
CTD_human |
Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome.
|
12736803 |
2003 |
Advanced Sleep Phase Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome.
|
12736803 |
2003 |
Non-24 Hour Sleep-Wake Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome.
|
12736803 |
2003 |
Shift-Work Sleep Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome.
|
12736803 |
2003 |
Sleep Disorders, Circadian Rhythm
|
0.300 |
Biomarker
|
group |
CTD_human |
Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome.
|
12736803 |
2003 |
Mental Depression
|
0.300 |
Biomarker
|
disease |
PSYGENET |
The mutant, AANAT knocked down C57BL/6J mice displayed significantly longer times of immobility ("depression").
|
11316327 |
2001 |
Depressive disorder
|
0.300 |
Biomarker
|
disease |
PSYGENET |
The mutant, AANAT knocked down C57BL/6J mice displayed significantly longer times of immobility ("depression").
|
11316327 |
2001 |
Diabetes Mellitus, Experimental
|
0.200 |
Biomarker
|
disease |
RGD |
Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes.
|
18624957 |
2008 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.200 |
Biomarker
|
disease |
RGD |
Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status.
|
16441550 |
2006 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function.
|
29844566 |
2018 |
Reticulocyte count (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Malignant neoplasm of breast
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
For combined heterozygotes and rare homozygotes a slightly elevated breast cancer risk was found for rs8150 in gene AANAT (OR 1.17; 95% CI 1.01-1.36), and a reduced risk for rs3816358 in gene ARNTL (OR 0.82; 95% CI 0.69-0.97) in the complete study population.
|
25229211 |
2014 |
Breast Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
For combined heterozygotes and rare homozygotes a slightly elevated breast cancer risk was found for rs8150 in gene AANAT (OR 1.17; 95% CI 1.01-1.36), and a reduced risk for rs3816358 in gene ARNTL (OR 0.82; 95% CI 0.69-0.97) in the complete study population.
|
25229211 |
2014 |
Malignant neoplasm of breast
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
In the main effects analysis, CC carriers of rs4238989 and GG carriers of rs3760138 in the AANAT gene had increased risk of breast cancer, whereas TT carriers of BMAL1 rs2278749 and TT carriers of CLOCK rs3749474 had reduced risk.
|
23822714 |
2013 |
Breast Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
In the main effects analysis, CC carriers of rs4238989 and GG carriers of rs3760138 in the AANAT gene had increased risk of breast cancer, whereas TT carriers of BMAL1 rs2278749 and TT carriers of CLOCK rs3749474 had reduced risk.
|
23822714 |
2013 |
Malignant neoplasm of breast
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
No significant breast cancer associations were found for variants in the AANAT gene.
|
22138747 |
2012 |
Breast Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
No significant breast cancer associations were found for variants in the AANAT gene.
|
22138747 |
2012 |
Colorectal Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.
|
28604612 |
2017 |
Autism Spectrum Disorders
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our results elucidate the enzymatic mechanism for melatonin deficit in ASD, involving a reduction of both enzyme activities contributing to melatonin synthesis (AANAT and ASMT), observed in the pineal gland as well as in gut and platelets of patients.
|
28522826 |
2017 |
Malignant neoplasm of colon and/or rectum
|
0.020 |
Biomarker
|
disease |
BEFREE |
AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.
|
28604612 |
2017 |
Colorectal Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Finally, a significant correlation was observed between AA-NAT and edn-1 expression downregulation in human colorectal cancer tissues.
|
24628039 |
2014 |